跳至主要内容
临床试验/NCT01548326
NCT01548326Unknown4 期

Effects of Short-term Atorvastatin Treatment on Vaccination Efficacy in Nonresponder Persons to Hepatitis B Vaccine

Nematollah Jonaidi Jafari1 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2011年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
52
试验地点
1
主要终点
Change from baseline in serum HBsAb level

研究概览

简要总结

The purpose of this study is to determine whether short-term Atorvastatin can increase the immunity response to hepatitis B vaccination in vaccine Nonresponders.

详细描述

20 person of vaccinated individuals who have HBsAb<10 after 3 dose hepatitis B vaccination who called Nonresponders will be randomly allocated in 2 groups. one group receive short-term Atorvastatin and other group receive placebo.both group will be vaccinated with hepatitis B vaccine and then immunity response will be measured.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • Previous 3 dose hepatitis B vaccination
  • Negative HBc Ab
  • Negative HBs Ag
  • HBs Ab less than 10 in ELIZA

排除标准

  • positive serologic evidence of Hepatitis B infection
  • Chronic use of Atorvastatin
  • Immunosuppressive Disease

研究组 & 干预措施

Atorvastatin

Active Comparator

will receive one 40 mg Atorvastatin tablet orally per day for 10 days and in 5th day 1 dose of recombinant yeast-derived Hepatitis B vaccine intramuscular in left Deltoid muscle

干预措施: Atorvastatin (Drug)

Placebo

Placebo Comparator

will receive one Placebo tablet orally per day for 10 days and in 5th day 1 dose of recombinant yeast-derived Hepatitis B vaccine intramuscular in left Deltoid muscle

干预措施: placebo (Drug)

结局指标

主要结局

Change from baseline in serum HBsAb level

时间窗: 1 month after vaccination

HBsAb level in serum measurement with quantitative ELIZA method

次要结局

  • IL-4 level in WBC culture(1 month after vaccination)
  • IL 17 level in WBC culture(1 month after vaccination)
  • TGF-beta level in WBC culture(1 month after vaccination)
  • IFN-gamma level in WBC culture(1 month after vaccination)

研究者

发起方
Nematollah Jonaidi Jafari
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Nematollah Jonaidi Jafari

Head of Health Research Center

Baqiyatallah Medical Sciences University

研究点 (1)

Loading locations...

相似试验